1-1 of 1
Authors: Su Jin Lee
Journal Article
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)
The Oncologist, Volume 20, Issue 11, November 2015, Pages 1312–1319, https://doi.org/10.1634/theoncologist.2015-0161
Published: 30 September 2015
